Unique Missions Of FDA, CMS Underscored In Presentations To HHS Panel
This article was originally published in The Gray Sheet
Executive Summary
Ongoing attempts to coordinate FDA and CMS reviews will preserve approval, coverage, coding and payment as distinct processes, agency representatives concurred at the HHS Secretary's Advisory Committee on Regulatory Reform regional hearing June 10